SCHEMBL29411413

SCHEMBL29411413

O=C(NCCCc1ccc(-c2ccccc2F)cc1)c1cc[nH]n1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 2/20 0.49
ALDH1A1 P00352 2/20 0.46
MAPT P10636 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MEN1 O00255 1/20 0.46
CYP3A4 P08684 1/20 0.46
TSHR P16473 1/20 0.46
MAPKAPK2 P49137 1/20 0.46
KMT2A Q03164 1/20 0.46
TDP1 Q9NUW8 1/20 0.45
FAAH O00519 2/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
CNR1 P21554 1/20 0.42
NAMPT P43490 1/20 0.42
GRIA4 P48058 1/20 0.41
ASAH1 Q13510 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21045536 1.00 HIF1A (0.49) HIF1AALDH1A1MAPTSMN1; SMN2MEN1
SCHEMBL29411545 0.81 LMNA (0.51) HIF1AALDH1A1MAPTSMN1; SMN2MEN1
SCHEMBL21045397 0.81 LMNA (0.51) HIF1AALDH1A1MAPTSMN1; SMN2MEN1
SCHEMBL21045228 0.80 ROCK2 (0.51) HIF1AALDH1A1MAPTSMN1; SMN2MEN1
SCHEMBL29411521 0.80 ROCK2 (0.51) HIF1AALDH1A1MAPTSMN1; SMN2MEN1
SCHEMBL21045160 0.80 HIF1A (0.49) HIF1AALDH1A1MAPTSMN1; SMN2MEN1
SCHEMBL29411641 0.80 HIF1A (0.49) HIF1AALDH1A1MAPTSMN1; SMN2MEN1
SCHEMBL21045396 0.79 HIF1A (0.50) HIF1AALDH1A1MAPTSMN1; SMN2MEN1
SCHEMBL29411495 0.79 HIF1A (0.50) HIF1AALDH1A1MAPTSMN1; SMN2MEN1
SCHEMBL21045096 0.79 HIF1A (0.54) HIF1AALDH1A1SMN1; SMN2MEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188035-A1 TUBULIN INHIBITORS LIN BIOSCIENCE LLC (US) 2025-06-12 US disclosed
US-12247010-B2 Tubulin inhibitors LIN BIOSCIENCE INC. (TW) 2025-03-11 US disclosed
US-20220089539-A1 TUBULIN INHIBITORS LIN BIOSCIENCE INC. (TW) 2022-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220089539-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB HIF1A 3747/4885ALDH1A1 3048/4885MAPT 24/4885
US-12247010-B2 Tubulin inhibitors TUBB3, TUBB1, TUBB HIF1A 3747/4885ALDH1A1 3048/4885MAPT 24/4885
US-20250188035-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB HIF1A 3747/4885ALDH1A1 3048/4885MAPT 24/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.